메뉴 건너뛰기




Volumn 2017, Issue 12, 2013, Pages

Interventions for smoking cessation and reduction in individuals with schizophrenia

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ATOMOXETINE; CARBON DIOXIDE; CLOZAPINE; GALANTAMINE; NALTREXONE; NICOTINE PATCH; PLACEBO; TOPIRAMATE; VARENICLINE; ANTIDEPRESSANT AGENT; BENZAZEPINE DERIVATIVE; NICOTINE; NICOTINE GUM; NICOTINIC AGENT; QUINOXALINE DERIVATIVE;

EID: 84875486671     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007253.pub3     Document Type: Review
Times cited : (119)

References (185)
  • 1
    • 64149109548 scopus 로고    scopus 로고
    • Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia
    • Horst W, Klein MW, Williams D, Werder SF. Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia. Neuropsychiatric Disease and Treatment 2005;1(4):349-55.
    • (2005) Neuropsychiatric Disease and Treatment , vol.1 , Issue.4 , pp. 349-355
    • Horst, W.1    Klein, M.W.2    Williams, D.3    Werder, S.F.4
  • 2
    • 33751324165 scopus 로고    scopus 로고
    • A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder
    • Baker A, Richmond R, Haile M, Lewin TJ, Carr VJ, Taylor RL, et al. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry 2006;163:1934-42.
    • (2006) American Journal of Psychiatry , vol.163 , pp. 1934-1942
    • Baker, A.1    Richmond, R.2    Haile, M.3    Lewin, T.J.4    Carr, V.J.5    Taylor, R.L.6
  • 3
    • 33847762234 scopus 로고    scopus 로고
    • Characteristics of smokers with a psychotic disorder and implications for smoking interventions
    • Baker A, Richmond R, Haile M, Lewin TJ, Carr VJ, Taylor RL, et al. Characteristics of smokers with a psychotic disorder and implications for smoking interventions. Psychiatry Research 2007;150:141-152.
    • (2007) Psychiatry Research , vol.150 , pp. 141-152
    • Baker, A.1    Richmond, R.2    Haile, M.3    Lewin, T.J.4    Carr, V.J.5    Taylor, R.L.6
  • 5
    • 84961915048 scopus 로고    scopus 로고
    • Intervention for tobacco dependence among people with a psychotic illness: RCT with one year outcome
    • Richmond RL, Baker A, Haile M, Carr V, Lewin T, Wilhelm K, et al. Intervention for tobacco dependence among people with a psychotic illness: RCT with one year outcome. Nicotine & Tobacco Research 2005;7(4):681.
    • (2005) Nicotine & Tobacco Research , vol.7 , Issue.4 , pp. 681
    • Richmond, R.L.1    Baker, A.2    Haile, M.3    Carr, V.4    Lewin, T.5    Wilhelm, K.6
  • 6
    • 84873283573 scopus 로고    scopus 로고
    • A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalised schizophrenic patients
    • epub
    • Chen H-K, Lan T-H, Wu B-J. A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalised schizophrenic patients. European Archives of Psychiatry and Clinical Neuroscience 2012;epub:doi: 10.1007/s00406-012-0338-3.
    • (2012) European Archives of Psychiatry and Clinical Neuroscience
    • Chen, H.-K.1    Lan, T.-H.2    Wu, B.-J.3
  • 8
    • 0035191220 scopus 로고    scopus 로고
    • A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia
    • Evins A, Mays VK, Rigotti NA, Tisdale T, Cather C, Goff DC. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine & Tobacco Research 2001;3(4):397-403.
    • (2001) Nicotine & Tobacco Research , vol.3 , Issue.4 , pp. 397-403
    • Evins, A.1    Mays, V.K.2    Rigotti, N.A.3    Tisdale, T.4    Cather, C.5    Goff, D.C.6
  • 9
    • 2342620106 scopus 로고    scopus 로고
    • Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction
    • Evins AE, Cather C, Rigotti NA, Freudenreich O, Henderson DC, Olm-Shipman CM, et al. Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction. Journal of Clinical Psychiatry 2004;65(3):307-11.
    • (2004) Journal of Clinical Psychiatry , vol.65 , Issue.3 , pp. 307-311
    • Evins, A.E.1    Cather, C.2    Rigotti, N.A.3    Freudenreich, O.4    Henderson, D.C.5    Olm-Shipman, C.M.6
  • 13
    • 77951726850 scopus 로고    scopus 로고
    • Smoking cessation in schizophrenia: A double blind placebo controlled trial of bupropion SR added to cognitive behavioral therapy
    • Evins AE, Cather C, Culhane M, Freudenreich O, Rigotti NA, Goff DC. Smoking cessation in schizophrenia: A double blind placebo controlled trial of bupropion SR added to cognitive behavioral therapy. Biological Psychiatry 2004;55:226S.
    • (2004) Biological Psychiatry , vol.55 , pp. 226S
    • Evins, A.E.1    Cather, C.2    Culhane, M.3    Freudenreich, O.4    Rigotti, N.A.5    Goff, D.C.6
  • 16
    • 34447542609 scopus 로고    scopus 로고
    • A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia
    • Evins A, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, et al. A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Journal of Clinical Psychopharmacology 2007;27(4):380-6.
    • (2007) Journal of Clinical Psychopharmacology , vol.27 , Issue.4 , pp. 380-386
    • Evins, A.1    Cather, C.2    Culhane, M.A.3    Birnbaum, A.4    Horowitz, J.5    Hsieh, E.6
  • 19
    • 40949150642 scopus 로고    scopus 로고
    • A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses
    • Gallagher SM, Penn PE, Schindler E, Layne W. A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses. Journal of Psychoactive Drugs 2007;39(4):487-97.
    • (2007) Journal of Psychoactive Drugs , vol.39 , Issue.4 , pp. 487-497
    • Gallagher, S.M.1    Penn, P.E.2    Schindler, E.3    Layne, W.4
  • 20
    • 77951739789 scopus 로고    scopus 로고
    • Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials
    • George TP, Hitsman B, Papandonatos GD, Sacco KA, Vessicchio JC, Dudas M, et al. Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials. Neuropsychopharmacology 2004;29 Suppl 1:S103.
    • (2004) Neuropsychopharmacology , vol.29 , pp. S103
    • George, T.P.1    Hitsman, B.2    Papandonatos, G.D.3    Sacco, K.A.4    Vessicchio, J.C.5    Dudas, M.6
  • 23
    • 77951739789 scopus 로고    scopus 로고
    • Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials
    • George TP, Hitsman B, Papandonatos GD, Sacco KA, Vessicchio JC, Dudas M, et al. Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials. Neuropsychopharmacology 2004;29 Suppl 1:S103.
    • (2004) Neuropsychopharmacology , vol.29 , pp. S103
    • George, T.P.1    Hitsman, B.2    Papandonatos, G.D.3    Sacco, K.A.4    Vessicchio, J.C.5    Dudas, M.6
  • 27
    • 77951739789 scopus 로고    scopus 로고
    • Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials
    • George TP, Hitsman B, Papandonatos GD, Sacco KA, Vessicchio JC, Dudas M, et al. Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials. Neuropsychopharmacology 2004;29 Suppl. 1:S103.
    • (2004) Neuropsychopharmacology , vol.29 , pp. S103
    • George, T.P.1    Hitsman, B.2    Papandonatos, G.D.3    Sacco, K.A.4    Vessicchio, J.C.5    Dudas, M.6
  • 28
    • 36049036635 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial of sustained-release bupropion combined with transdermal nicotine patch for smoking cessation in schizophrenia: Neuropsychological predictors of treatment outcome
    • George TP, Vessicchio J, Allen T, Weinberger A, Sacco KA. A randomized, double-blind, placebo-controlled trial of sustained-release bupropion combined with transdermal nicotine patch for smoking cessation in schizophrenia: Neuropsychological predictors of treatment outcome. Neuropsychopharmacology 2006;31 Suppl. 1:S254-5.
    • (2006) Neuropsychopharmacology , vol.31 , pp. S254-S255
    • George, T.P.1    Vessicchio, J.2    Allen, T.3    Weinberger, A.4    Sacco, K.A.5
  • 32
    • 77951281252 scopus 로고    scopus 로고
    • An efficacy analysis of bupropion for smoking cessation in schizophrenia
    • Li Jun, Zhang Tian-liang, Wang Bin, Li Xian-wei. An efficacy analysis of bupropion for smoking cessation in schizophrenia. Zhongguo Xinyao yu Linchuang Zazhi 2009;28(3):231-4.
    • (2009) Zhongguo Xinyao yu Linchuang Zazhi , vol.28 , Issue.3 , pp. 231-234
    • Li, J.1    Zhang, T.-L.2    Wang, B.3    Li, X.-W.4
  • 33
    • 85036516768 scopus 로고    scopus 로고
    • Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia
    • (accessed on 31/03/2010)
    • Weiner E. Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00554840 (accessed on 31/03/2010).
    • Weiner, E.1
  • 34
    • 79956066309 scopus 로고    scopus 로고
    • Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study
    • 6459]
    • Weiner E, Buchholz A, Coffay A, Liu F, McMahon RP, Buchanan RW, et al. Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study. Schizophrenia Research 2011;129(1):94-5. [; 6459]
    • (2011) Schizophrenia Research , vol.129 , Issue.1 , pp. 94-95
    • Weiner, E.1    Buchholz, A.2    Coffay, A.3    Liu, F.4    McMahon, R.P.5    Buchanan, R.W.6
  • 36
    • 84856249784 scopus 로고    scopus 로고
    • Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis
    • United States
    • Weiner E, Ball MP, Buchholz AS, Gold JM, Evins AE, McMahon RP, et al. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis. Journal of Clinical Psychiatry. United States, 2012; Vol. 73, issue 1:95-102. []
    • (2012) Journal of Clinical Psychiatry , vol.73 , Issue.1 , pp. 95-102
    • Weiner, E.1    Ball, M.P.2    Buchholz, A.S.3    Gold, J.M.4    Evins, A.E.5    McMahon, R.P.6
  • 37
    • 27744453317 scopus 로고    scopus 로고
    • A comparison of bupropion SR and placebo for smoking cessation in schizophrenia
    • Weiner E, Buchanan R, Gold J, Ball P, Bennett M. A comparison of bupropion SR and placebo for smoking cessation in schizophrenia. Schizophrenia Research 2003;60:305-6.
    • (2003) Schizophrenia Research , vol.60 , pp. 305-306
    • Weiner, E.1    Buchanan, R.2    Gold, J.3    Ball, P.4    Bennett, M.5
  • 39
    • 36448953959 scopus 로고    scopus 로고
    • Psychosocial Treatments for Individuals with Schizophrenia and Tobacco Dependence
    • Steinberg ML, Williams J. Psychosocial Treatments for Individuals with Schizophrenia and Tobacco Dependence. Journal of Dual Diagnosis 2007;3(3/4):99-112.
    • (2007) Journal of Dual Diagnosis , vol.3 , Issue.3-4 , pp. 99-112
    • Steinberg, M.L.1    Williams, J.2
  • 42
    • 85036565714 scopus 로고    scopus 로고
    • Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder
    • (accessed on 31/03/2010)
    • Pfizer. Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder. www.clinicaltrials.gov/ct2/show/NCT00644969 (accessed on 31/03/2010).
  • 43
    • 84861838749 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder
    • United States
    • Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, et al. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry. United States, 2012; Vol. 73, issue 5:654-60. []
    • (2012) Journal of Clinical Psychiatry , vol.73 , Issue.5 , pp. 654-660
    • Williams, J.M.1    Anthenelli, R.M.2    Morris, C.D.3    Treadow, J.4    Thompson, J.R.5    Yunis, C.6
  • 44
    • 85036540276 scopus 로고    scopus 로고
    • rTMS Effects on Smoking Cessation and Cognition in Schizophrenia
    • (accessed on 31/03/2010)
    • George T. rTMS Effects on Smoking Cessation and Cognition in Schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00736710 (accessed on 31/03/2010).
    • George, T.1
  • 47
    • 79953124060 scopus 로고    scopus 로고
    • A double-blind placebo-controlled trial of bupropion for smoking abstinence and cognition improvement in schizophrenia
    • Akbarpour F, Rezaei O, Khodaie-Ardakani MR, Sheikhvatan M, Goodarzi H, Dolatshahi B. A double-blind placebo-controlled trial of bupropion for smoking abstinence and cognition improvement in schizophrenia. Minerva Psichiatrica 2010; Vol. 51, issue 4:263-9. []
    • (2010) Minerva Psichiatrica , vol.51 , Issue.4 , pp. 263-269
    • Akbarpour, F.1    Rezaei, O.2    Khodaie-Ardakani, M.R.3    Sheikhvatan, M.4    Goodarzi, H.5    Dolatshahi, B.6
  • 48
    • 72049105573 scopus 로고    scopus 로고
    • Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia
    • Bloch B, Reshef A, Cohen T, Tafla A, Gathas S, Israel S, et al. Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia. Psychiatry Research 2010; Vol. 175, issue 1-2:38-42.
    • (2010) Psychiatry Research , vol.175 , Issue.1-2 , pp. 38-42
    • Bloch, B.1    Reshef, A.2    Cohen, T.3    Tafla, A.4    Gathas, S.5    Israel, S.6
  • 52
    • 0033085918 scopus 로고    scopus 로고
    • Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia
    • Dalack GW, Meador-Woodruff JH. Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia. Nicotine & Tobacco Research 1999;1(1):53-7.
    • (1999) Nicotine & Tobacco Research , vol.1 , Issue.1 , pp. 53-57
    • Dalack, G.W.1    Meador-Woodruff, J.H.2
  • 54
    • 20444391347 scopus 로고    scopus 로고
    • A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia [Letter to the Editor]
    • Fatemi S, Stary J, Hatsukami D, Murphy S. A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia [Letter to the Editor]. Schizophrenia Research 2005;76(2-3):353-6.
    • (2005) Schizophrenia Research , vol.76 , Issue.2-3 , pp. 353-356
    • Fatemi, S.1    Stary, J.2    Hatsukami, D.3    Murphy, S.4
  • 55
    • 84856729395 scopus 로고    scopus 로고
    • Nonmedication smoking reduction program for inpatients with chronic schizophrenia: a randomized control design study
    • United States: Lippincott Williams and Wilkins (351 West Camden Street, Baltimore MD 21201-2436, United States)
    • Gelkopf M, Noam S, Rudinski D, Lerner A, Behrbalk P, Bleich A, et al. Nonmedication smoking reduction program for inpatients with chronic schizophrenia: a randomized control design study. Journal of Nervous and Mental Disease. United States: Lippincott Williams and Wilkins (351 West Camden Street, Baltimore MD 21201-2436, United States), 2012; Vol. 200, issue 2:142-6. []
    • (2012) Journal of Nervous and Mental Disease , vol.200 , Issue.2 , pp. 142-146
    • Gelkopf, M.1    Noam, S.2    Rudinski, D.3    Lerner, A.4    Behrbalk, P.5    Bleich, A.6
  • 57
    • 85023776727 scopus 로고    scopus 로고
    • Engaging smokers with schizophrenia in treatment for tobacco dependence: A brief motivational interviewing intervention
    • 3-B:
    • Steinberg ML. Engaging smokers with schizophrenia in treatment for tobacco dependence: A brief motivational interviewing intervention. Dissertation Abstracts International: Section B: The Sciences and Engineering 2003; Vol. 64, issue 3-B:1508.
    • (2003) Dissertation Abstracts International: Section B: The Sciences and Engineering , vol.64 , pp. 1508
    • Steinberg, M.L.1
  • 58
    • 3343015673 scopus 로고    scopus 로고
    • Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence
    • Steinberg ML, Ziedonis DM, Krejci JA, Brandon TH. Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. Journal of Consulting & Clinical Psychology 2004;72(4):723-8.
    • (2004) Journal of Consulting & Clinical Psychology , vol.72 , Issue.4 , pp. 723-728
    • Steinberg, M.L.1    Ziedonis, D.M.2    Krejci, J.A.3    Brandon, T.H.4
  • 60
    • 85036495973 scopus 로고    scopus 로고
    • Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
    • (accessed on 31/03/2010)
    • Tidey JW. Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00136760 (accessed on 31/03/2010).
    • Tidey, J.W.1
  • 61
    • 82955235583 scopus 로고    scopus 로고
    • Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia
    • Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Reid N. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology 2011; Vol. 217, issue 2:279-87. []
    • (2011) Psychopharmacology , vol.217 , Issue.2 , pp. 279-287
    • Tidey, J.W.1    Rohsenow, D.J.2    Kaplan, G.B.3    Swift, R.M.4    Reid, N.5
  • 67
    • 47249094034 scopus 로고    scopus 로고
    • Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia
    • Kelly DL, McMahon RP, Weiner E, Boggs DL, Dickinson D, Conley RR, et al. Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia. Schizophrenia Research 2008;103(1-3):161-8.
    • (2008) Schizophrenia Research , vol.103 , Issue.1-3 , pp. 161-168
    • Kelly, D.L.1    McMahon, R.P.2    Weiner, E.3    Boggs, D.L.4    Dickinson, D.5    Conley, R.R.6
  • 69
    • 84965143587 scopus 로고    scopus 로고
    • Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia
    • (accessed on 31/03/2010)
    • Meszaros ZS. Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00727103 (accessed on 31/03/2010).
    • Meszaros, Z.S.1
  • 72
    • 84855866544 scopus 로고    scopus 로고
    • Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
    • Shim J C, Jung D U, Jung S S, Seo Y S, Cho D M, Lee J H, et al. Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial. Neuropsychopharmacology 2012;37(3):660-8.
    • (2012) Neuropsychopharmacology , vol.37 , Issue.3 , pp. 660-668
    • Shim, J.C.1    Jung, D.U.2    Jung, S.S.3    Seo, Y.S.4    Cho, D.M.5    Lee, J.H.6
  • 73
    • 84965095607 scopus 로고    scopus 로고
    • Varenicline treatment for smoking cessation in people with schizophrenia: A randomized double-blind placebo-controlled trial
    • Shim JC, Jung D, Oh M, Kong B, Ha T, Cho D, et al. Varenicline treatment for smoking cessation in people with schizophrenia: A randomized double-blind placebo-controlled trial. Schizophrenia Bulletin. 2011; Vol. 37:320-1. []
    • (2011) Schizophrenia Bulletin. , vol.37 , pp. 320-321
    • Shim, J.C.1    Jung, D.2    Oh, M.3    Kong, B.4    Ha, T.5    Cho, D.6
  • 74
    • 34548439468 scopus 로고    scopus 로고
    • A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type
    • Chengappa KNR, Kupfer DJ, Parepally H, John V, Basu R, Buttenfield J, et al. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type. Bipolar Disorder 2007;9(6):609-17.
    • (2007) Bipolar Disorder , vol.9 , Issue.6 , pp. 609-617
    • Chengappa, K.N.R.1    Kupfer, D.J.2    Parepally, H.3    John, V.4    Basu, R.5    Buttenfield, J.6
  • 76
    • 67649351930 scopus 로고    scopus 로고
    • Effects of topiramate on smoking patients with schizoaffective disorder, bipolar type: Response to Khazaal and Zullino
    • Weinberger AH, George TP, Perkins KA, Chengappa KNR. Effects of topiramate on smoking patients with schizoaffective disorder, bipolar type: Response to Khazaal and Zullino. Journal of Clinical Psychopharmacology 2009;29:193-194.
    • (2009) Journal of Clinical Psychopharmacology , vol.29 , pp. 193-194
    • Weinberger, A.H.1    George, T.P.2    Perkins, K.A.3    Chengappa, K.N.R.4
  • 77
    • 79955140463 scopus 로고    scopus 로고
    • Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study
    • Allen MH, Debanné M, Lazignac C, Adam E, Dickinson LM, Damsa C. Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study. American Journal of Psychiatry 2011;168(4):395-9.
    • (2011) American Journal of Psychiatry , vol.168 , Issue.4 , pp. 395-399
    • Allen, M.H.1    Debanné, M.2    Lazignac, C.3    Adam, E.4    Dickinson, L.M.5    Damsa, C.6
  • 78
    • 85036580477 scopus 로고    scopus 로고
    • Effect of nicotine replacement on agitation and aggression in smokers with schizophrenia: a double blind, randomized placebo controlled pilot study
    • 2009 May 16 21; San Francisco, CA. [30292]
    • Damsa C, Lazignac C, Adam E, Virgillito S, Allen MH. Effect of nicotine replacement on agitation and aggression in smokers with schizophrenia: a double blind, randomized placebo controlled pilot study. Proceedings of the 162nd Annual Meeting of the American Psychiatric Association; 2009 May 16 21; San Francisco, CA. 2009. [; 30292]
    • (2009) Proceedingsof the 162nd Annual Meeting of the American Psychiatric Association
    • Damsa, C.1    Lazignac, C.2    Adam, E.3    Virgillito, S.4    Allen, M.H.5
  • 79
    • 78651514903 scopus 로고    scopus 로고
    • Smoking Cessation in Women With Severe Mental Illness: Exploring the Role of Exercise as an Adjunct Treatment
    • Arbour-Nicitopoulos K P, Faulkner G E, Cohn T A, Selby P. Smoking Cessation in Women With Severe Mental Illness: Exploring the Role of Exercise as an Adjunct Treatment. Archives of Psychiatric Nursing 2011;25(1):43-52.
    • (2011) Archives of Psychiatric Nursing , vol.25 , Issue.1 , pp. 43-52
    • Arbour-Nicitopoulos, K.P.1    Faulkner, G.E.2    Cohn, T.A.3    Selby, P.4
  • 80
    • 80755128432 scopus 로고    scopus 로고
    • A pilot study examining the acute effects of exercise on cigarette cravings and affect among individuals with serious mental illness
    • Arbour-Nicitopoulos K P, Faulkner G E, Hsin A, Selby P. A pilot study examining the acute effects of exercise on cigarette cravings and affect among individuals with serious mental illness. Mental Health and Physical Activity 2011;4(2):89-94.
    • (2011) Mental Health and Physical Activity , vol.4 , Issue.2 , pp. 89-94
    • Arbour-Nicitopoulos, K.P.1    Faulkner, G.E.2    Hsin, A.3    Selby, P.4
  • 82
    • 75349090897 scopus 로고    scopus 로고
    • Smoking and schizophrenia: Treatment approaches within primary care
    • Baker Amanda L, Lubman Dan I, Hides Leanne. Smoking and schizophrenia: Treatment approaches within primary care. Primary Psychiatry 2010;17(1):49-54.
    • (2010) Primary Psychiatry , vol.17 , Issue.1 , pp. 49-54
    • Baker Amanda, L.1    Lubman Dan, I.2    Hides, L.3
  • 83
    • 77953316403 scopus 로고    scopus 로고
    • Smoking cessation in severe mental illness: What works?
    • Banham Lindsay, Gilbody Simon. Smoking cessation in severe mental illness: What works?. Addiction 2010;105(7):1176-89.
    • (2010) Addiction , vol.105 , Issue.7 , pp. 1176-1189
    • Banham, L.1    Gilbody, S.2
  • 84
    • 4544374306 scopus 로고    scopus 로고
    • Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders
    • Brown RA, Ramsey SE, Strong DR, Myers MG, Kahler CW, Lejuez CW, et al. Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders. Tobacco Control 2003;12 Suppl 4:iv3-iv10.
    • (2003) Tobacco Control , vol.12 , pp. 3-10
    • Brown, R.A.1    Ramsey, S.E.2    Strong, D.R.3    Myers, M.G.4    Kahler, C.W.5    Lejuez, C.W.6
  • 85
    • 79953692715 scopus 로고    scopus 로고
    • An Electronic Decision Support System to Motivate People With Severe Mental Illnesses to Quit Smoking
    • Brunette M F, Ferron J C, McHugo G J, Davis K E, Devitt T S, Wilkness S M, et al. An Electronic Decision Support System to Motivate People With Severe Mental Illnesses to Quit Smoking. Psychiatric Services 2011;62(4):360-6.
    • (2011) Psychiatric Services , vol.62 , Issue.4 , pp. 360-366
    • Brunette, M.F.1    Ferron, J.C.2    McHugo, G.J.3    Davis, K.E.4    Devitt, T.S.5    Wilkness, S.M.6
  • 86
    • 79961117860 scopus 로고    scopus 로고
    • A systematic review and meta-analysis of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups
    • Bryant J, Bonevski B, Paul C, McElduff P, Attia J. A systematic review and meta-analysis of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups. Addiction 2011;106 (9):1568-85.
    • (2011) Addiction , vol.106 , Issue.9 , pp. 1568-1585
    • Bryant, J.1    Bonevski, B.2    Paul, C.3    McElduff, P.4    Attia, J.5
  • 87
    • 85036581141 scopus 로고    scopus 로고
    • Varenicline as a smoking cessation aid in schizophrenia patients: Effects on smoking behavior and reward sensitivity
    • 1
    • Dutra SJ, Stoeckel LE, Carlini SV, Pizzagalli DA, Evins AE. Varenicline as a smoking cessation aid in schizophrenia patients: Effects on smoking behavior and reward sensitivity. Biological Psychiatry 2011; Vol. 69, issue 9 SUPPL. 1:280S. []
    • (2011) Biological Psychiatry , vol.69 , Issue.9 , pp. 280S
    • Dutra, S.J.1    Stoeckel, L.E.2    Carlini, S.V.3    Pizzagalli, D.A.4    Evins, A.E.5
  • 89
    • 85036581489 scopus 로고    scopus 로고
    • A Group Intervention which assists patients with dual diagnosis reduce their tobacco use
    • In: Abelian ME editor(s). Hauppauge, NY: Nova Science Publishers
    • Kisely SR, Preston NJ. A Group Intervention which assists patients with dual diagnosis reduce their tobacco use. In: Abelian ME editor(s). Trends in psychotherapy research. Hauppauge, NY: Nova Science Publishers, 2006:141-59.
    • (2006) Trends in psychotherapy research , pp. 141-159
    • Kisely, S.R.1    Preston, N.J.2
  • 91
    • 0033027553 scopus 로고    scopus 로고
    • Smoking and therapeutic response to clozapine in patients with schizophrenia
    • McEvoy JP, Freudenreich O, Wilson WH. Smoking and therapeutic response to clozapine in patients with schizophrenia. Biological Psychiatry 1999;46:125-9.
    • (1999) Biological Psychiatry , vol.46 , pp. 125-129
    • McEvoy, J.P.1    Freudenreich, O.2    Wilson, W.H.3
  • 92
    • 71649095211 scopus 로고    scopus 로고
    • Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behaviour, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study
    • McKee SA, Weinberger AH, Harrison ELR, Coppola S, George TP. Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behaviour, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study. Schizophrenia Research 2009;115:317-24.
    • (2009) Schizophrenia Research , vol.115 , pp. 317-324
    • McKee, S.A.1    Weinberger, A.H.2    Harrison, E.L.R.3    Coppola, S.4    George, T.P.5
  • 94
    • 84861412607 scopus 로고    scopus 로고
    • Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week Open-Label Trial
    • Pachas G N, Cather C, Pratt S I, Hoeppner B, Nino J, Carlini S V, et al. Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week Open-Label Trial. Journal of Dual Diagnosis 2012;8(2):117-25.
    • (2012) Journal of Dual Diagnosis , vol.8 , Issue.2 , pp. 117-125
    • Pachas, G.N.1    Cather, C.2    Pratt, S.I.3    Hoeppner, B.4    Nino, J.5    Carlini, S.V.6
  • 95
    • 0031779583 scopus 로고    scopus 로고
    • Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: a feasibility study
    • Roll JM, Higgins ST, Steingard S, McGinley M. Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: a feasibility study. Experimental & Clinical Psychopharmacology 1998;6(2):157-61.
    • (1998) Experimental & Clinical Psychopharmacology , vol.6 , Issue.2 , pp. 157-161
    • Roll, J.M.1    Higgins, S.T.2    Steingard, S.3    McGinley, M.4
  • 97
    • 85047682250 scopus 로고    scopus 로고
    • Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia
    • Tidey JW, O'Neill SC, Higgins ST. Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Experimental & Clinical Psychopharmacology 2002;10(3):241-7.
    • (2002) Experimental & Clinical Psychopharmacology , vol.10 , Issue.3 , pp. 241-247
    • Tidey, J.W.1    O'Neill, S.C.2    Higgins, S.T.3
  • 99
    • 0035065999 scopus 로고    scopus 로고
    • Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia
    • Weiner E, Ball MP, Summerfelt A, Gold J, Buchanan RW. Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. American Journal of Psychiatry 2001;158(4):635-7.
    • (2001) American Journal of Psychiatry , vol.158 , Issue.4 , pp. 635-637
    • Weiner, E.1    Ball, M.P.2    Summerfelt, A.3    Gold, J.4    Buchanan, R.W.5
  • 100
    • 85036506234 scopus 로고    scopus 로고
    • Increasing motivation to stop smoking among persons with schizophrenia and other chronic mental illnesses
    • 8-B
    • Wells ME. Increasing motivation to stop smoking among persons with schizophrenia and other chronic mental illnesses. Dissertation Abstracts International: Section B: The Sciences and Engineering 2003; Vol. 63, issue 8-B.
    • (2003) Dissertation Abstracts International: Section B: The Sciences and Engineering , vol.63
    • Wells, M.E.1
  • 101
    • 85036542809 scopus 로고    scopus 로고
    • The impact of smoking cessation programs on schizophrenic patients' smoking behaviors [abstract]
    • Chen R, Ku C, Chou K, Shen C. The impact of smoking cessation programs on schizophrenic patients' smoking behaviors [abstract]. American Journal of Respiratory and Critical Care Medicine 2002;165(8 Suppl):A309.
    • (2002) American Journal of Respiratory and Critical Care Medicine , vol.165 , Issue.8 , pp. A309
    • Chen, R.1    Ku, C.2    Chou, K.3    Shen, C.4
  • 102
    • 1242323583 scopus 로고    scopus 로고
    • The impact of smoking cessation programs on smoking-related health belief and rate of quit-smoking among schizophrenic patients
    • Chen R, Ku C-H, Lu R-B, Chou K-R. The impact of smoking cessation programs on smoking-related health belief and rate of quit-smoking among schizophrenic patients. Journal of Medical Sciences 2002;22(5):215-20.
    • (2002) Journal of Medical Sciences , vol.22 , Issue.5 , pp. 215-220
    • Chen, R.1    Ku, C.-H.2    Lu, R.-B.3    Chou, K.-R.4
  • 103
    • 1242351546 scopus 로고    scopus 로고
    • The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia
    • Chou KR, Chen R, Lee JF, Ku CH, Lu RB. The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. International Journal of Nursing Studies 2004;41(3):321-30.
    • (2004) International Journal of Nursing Studies , vol.41 , Issue.3 , pp. 321-330
    • Chou, K.R.1    Chen, R.2    Lee, J.F.3    Ku, C.H.4    Lu, R.B.5
  • 104
    • 85036506390 scopus 로고    scopus 로고
    • Healthy lifestyle intervention for cardiovascular disease risk reduction among smokers with psychotic disorders
    • (accessed on 11/4/2010)
    • Baker A. Healthy lifestyle intervention for cardiovascular disease risk reduction among smokers with psychotic disorders. www.anzctr.org.au/trial_view.aspx?ID=308232 (accessed on 11/4/2010).
    • Baker, A.1
  • 106
    • 78650799024 scopus 로고    scopus 로고
    • Study protocol: a randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders
    • Baker A, Kay-Lambkin FJ, Richmond R, Filia S, Castle D, Williams J, et al. Study protocol: a randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders. BMC Public Health 2011; Vol. 11, issue 1:10.
    • (2011) BMC Public Health , vol.11 , Issue.1 , pp. 10
    • Baker, A.1    Kay-Lambkin, F.J.2    Richmond, R.3    Filia, S.4    Castle, D.5    Williams, J.6
  • 107
    • 85036555191 scopus 로고    scopus 로고
    • Randomised controlled trial of a healthy lifestyles intervention to reduce cardiovascular disease (CVD) risk among smokers with psychosis: Interim results
    • Filia S, Baker A, Richmond R, Kay-Lambkin F, Castle D, Williams J, et al. Randomised controlled trial of a healthy lifestyles intervention to reduce cardiovascular disease (CVD) risk among smokers with psychosis: Interim results. Australian and New Zealand Journal of Psychiatry 2010;44:A31-A32. []
    • (2010) Australian and New Zealand Journal of Psychiatry , vol.44 , pp. A31-A32
    • Filia, S.1    Baker, A.2    Richmond, R.3    Kay-Lambkin, F.4    Castle, D.5    Williams, J.6
  • 108
    • 85036567656 scopus 로고    scopus 로고
    • Smoking cessation for veterans with severe and persistent mental illness
    • (accessed on 20/7/12)
    • Dixon L B, Potts W. Smoking cessation for veterans with severe and persistent mental illness. www.clinicaltrials.gov/ct2/show/NCT00960375 (accessed on 20/7/12).
    • Dixon, L.B.1    Potts, W.2
  • 109
    • 85036591060 scopus 로고    scopus 로고
    • A study of Varenicline for Prevention of Relapse to Smoking in Patients with Schizophrenia or Bipolar Disorder (SCRP)
    • (accessed on 12/11/2012)
    • Evins AE. A study of Varenicline for Prevention of Relapse to Smoking in Patients with Schizophrenia or Bipolar Disorder (SCRP). www.clinicaltrials.gov/ct2/show/NCT00621777 (accessed on 12/11/2012).
    • Evins, A.E.1
  • 110
    • 85036580089 scopus 로고    scopus 로고
    • Varenicline and smoking cessation in schizophrenia (VSCS)
    • accessed on 20/7/12
    • Fatemi SH. Varenicline and smoking cessation in schizophrenia (VSCS). http://www.clinicaltrials.gov/ct2/show/NCT01111149 (accessed on 20/7/12).
    • Fatemi, S.H.1
  • 111
    • 85036581076 scopus 로고    scopus 로고
    • Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia
    • (accessed on 31/03/2010)
    • Josiassen RJ. Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia. www.clinicaltrials.gov/ct2/show/NCT00231101 (accessed on 31/03/2010).
    • Josiassen, R.J.1
  • 112
    • 85036532372 scopus 로고    scopus 로고
    • Contingency Management for Smoking Cessation Among Veterans With Psychotic Disorders
    • (accessed on 12/11/2012)
    • Saxon AJ. Contingency Management for Smoking Cessation Among Veterans With Psychotic Disorders. www.clinicaltrials.gov/ct2/show/NCT00508560 (accessed on 12/11/2012).
    • Saxon, A.J.1
  • 113
    • 85036538893 scopus 로고    scopus 로고
    • Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
    • (accessed on 12/11/2012)
    • Smith RC. Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors. www.clinicaltrials.gov/ct2/show/NCT00802919 (accessed on 12/11/2012).
    • Smith, R.C.1
  • 114
    • 85036582179 scopus 로고    scopus 로고
    • The effect of an integrated smoking care program on the reduction and abstinence of smoking in mental health inpatients following discharge from hospital
    • (accessed on 16/11/2012)
    • The effect of an integrated smoking care program on the reduction and abstinence of smoking in mental health inpatients following discharge from hospital. http://www.anzctr.org.au/trial_view.aspx?ID=83938 (accessed on 16/11/2012).
  • 115
    • 79960555497 scopus 로고    scopus 로고
    • A randomised controlled trial linking mental health inpatients to community smoking cessation supports: a study protocol
    • Stockings EA, Bowman JA, Wiggers J, Baker AL, Terry M, Clancy R, et al. A randomised controlled trial linking mental health inpatients to community smoking cessation supports: a study protocol. BMC Public Health 2011;11:570.
    • (2011) BMC Public Health , vol.11 , pp. 570
    • Stockings, E.A.1    Bowman, J.A.2    Wiggers, J.3    Baker, A.L.4    Terry, M.5    Clancy, R.6
  • 116
    • 85036588023 scopus 로고    scopus 로고
    • Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia
    • accessed on 12/11/2012
    • Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia. http://www.clinicaltrials.gov/ct2/show/NCT01010477 (accessed on 12/11/2012).
  • 118
    • 84870481181 scopus 로고
    • 4th Edition. Washington, DC: American Psychiatric Association
    • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder. 4th Edition. Washington, DC: American Psychiatric Association, 1994.
    • (1994) Diagnostic and Statistical Manual of Mental Disorder
  • 119
    • 62649107855 scopus 로고    scopus 로고
    • Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption
    • Amiaz R, Levy D, Vainiger D, Grunhaus L, Zangen A. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction 2009;104(4):653-660.
    • (2009) Addiction , vol.104 , Issue.4 , pp. 653-660
    • Amiaz, R.1    Levy, D.2    Vainiger, D.3    Grunhaus, L.4    Zangen, A.5
  • 122
    • 79955667672 scopus 로고    scopus 로고
    • Competitions and incentives for smoking cessation
    • Cahill K, Perera R. Competitions and incentives for smoking cessation. Cochrane Database of Systematic Reviews 2011, Issue 4. [DOI: 10.1002/14651858.CD004307.pub4]
    • (2011) Cochrane Database of Systematic Reviews , Issue.4
    • Cahill, K.1    Perera, R.2
  • 124
    • 84865758663 scopus 로고    scopus 로고
    • Does Varenicline Worsen Psychiatric Symptoms in Patients With Schizophrenia or Schizoaffective Disorder? A Review of Published Studies
    • Cerimele JM, Durango A. Does Varenicline Worsen Psychiatric Symptoms in Patients With Schizophrenia or Schizoaffective Disorder? A Review of Published Studies. Journal of Clinical Psychiatry 2012;73(8):e1039-1047.
    • (2012) Journal of Clinical Psychiatry , vol.73 , Issue.8
    • Cerimele, J.M.1    Durango, A.2
  • 125
    • 0037560389 scopus 로고    scopus 로고
    • Balancing benefits and harms in health care
    • Cuervo LG, Clarke M. Balancing benefits and harms in health care. British Medical Journal 2003;327(7406):65-66.
    • (2003) British Medical Journal , vol.327 , Issue.7406 , pp. 65-66
    • Cuervo, L.G.1    Clarke, M.2
  • 127
    • 20444463577 scopus 로고    scopus 로고
    • A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors
    • de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research 2005;76(2/3):135-57.
    • (2005) Schizophrenia Research , vol.76 , Issue.2-3 , pp. 135-157
    • de Leon, J.1    Diaz, F.J.2
  • 128
    • 0034958715 scopus 로고    scopus 로고
    • Smoking in patients receiving psychotropic medications: A pharmacokinetic perspective
    • Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: A pharmacokinetic perspective. CNS Drugs 2001;15(6):469-94.
    • (2001) CNS Drugs , vol.15 , Issue.6 , pp. 469-494
    • Desai, H.D.1    Seabolt, J.2    Jann, M.W.3
  • 129
    • 0033105779 scopus 로고    scopus 로고
    • Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes
    • Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophrenia Research 1999;35 Suppl:S93-S100.
    • (1999) Schizophrenia Research , vol.35 , pp. S93-S100
    • Dixon, L.1
  • 133
    • 67649261299 scopus 로고    scopus 로고
    • Public Health Advisory: Important Information on Chantix (varenicline)
    • (accessed on 30/11/12)
    • US Food, Drug Administration. Public Health Advisory: Important Information on Chantix (varenicline). http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm051136.htm (accessed on 30/11/12).
  • 134
    • 84455194972 scopus 로고    scopus 로고
    • FDA drug safety communication: safety review update of Chantix (varenicline) and risk of neuropsychiatric adverse events
    • (accessed 30/11/2012) October
    • US Food, Drug Administration. [FDA drug safety communication: safety review update of Chantix (varenicline) and risk of neuropsychiatric adverse events.]. http://www.fda.gov/Drugs/DrugSafety/ucm276737.htm (accessed 30/11/2012) October 2011.
    • (2011)
  • 136
    • 34548071446 scopus 로고    scopus 로고
    • Exacerbation of schizophrenia by varenicline
    • Freedman R. Exacerbation of schizophrenia by varenicline. American Journal of Psychiatry 2007;164:1269.
    • (2007) American Journal of Psychiatry , vol.164 , pp. 1269
    • Freedman, R.1
  • 137
    • 85013798232 scopus 로고    scopus 로고
    • Prescribing Information (Wellbutrin XL - bupropion hydrochloride extended-release tablets)
    • Prescribing Information (Wellbutrin XL - bupropion hydrochloride extended-release tablets). http://us.gsk.com/products/assets/us_wellbutrinXL.pdf 2008.
    • (2008)
  • 138
    • 0026800996 scopus 로고
    • Cigarette smoking in schizophrenia: Relaitonship to psychopathology and medication side effects
    • Goff DC, Henderson DC, Amico E. Cigarette smoking in schizophrenia: Relaitonship to psychopathology and medication side effects. American Journal of Psychiatry 1992;149(9):1189-94.
    • (1992) American Journal of Psychiatry , vol.149 , Issue.9 , pp. 1189-1194
    • Goff, D.C.1    Henderson, D.C.2    Amico, E.3
  • 139
    • 70449392796 scopus 로고    scopus 로고
    • Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database
    • Gunnell D, Irvine D, Wise L, Davies C, Martin RM. Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. British Medical Journal 2009;339:b3805.
    • (2009) British Medical Journal , vol.339
    • Gunnell, D.1    Irvine, D.2    Wise, L.3    Davies, C.4    Martin, R.M.5
  • 140
    • 0026848643 scopus 로고
    • Operant conditioning of activities of daily living on a psychogeriatric ward: A simple method
    • Gustafson R. Operant conditioning of activities of daily living on a psychogeriatric ward: A simple method. Psychological Reports 1992;70:603-7.
    • (1992) Psychological Reports , vol.70 , pp. 603-607
    • Gustafson, R.1
  • 141
    • 80051599762 scopus 로고    scopus 로고
    • Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand
    • Harrison-Woolrych M, Ashton J. Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand. Drug Safety 2011;34(9):763-772.
    • (2011) Drug Safety , vol.34 , Issue.9 , pp. 763-772
    • Harrison-Woolrych, M.1    Ashton, J.2
  • 143
    • 85100415918 scopus 로고    scopus 로고
    • Cochrane Handbook for Systematic Reviews of Interventions,5.1.0 [updated March 2011]
    • The Cochrane Collaboration
    • Higgins JPT, Green S [eds]. Cochrane Handbook for Systematic Reviews of Interventions, 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
    • (2011)
    • Higgins, J.P.T.1    Green, S.2
  • 144
    • 23444434489 scopus 로고    scopus 로고
    • The feasibility of smoking reduction: an update
    • Hughes JR, Carpenter MJ. The feasibility of smoking reduction: an update. Addiction 2005;100:1074-89.
    • (2005) Addiction , vol.100 , pp. 1074-1089
    • Hughes, J.R.1    Carpenter, M.J.2
  • 145
    • 33751583834 scopus 로고    scopus 로고
    • Does smoking reduction increase future cessation and decrease disease risk? A qualitative review
    • Hughes JR, Carpenter MJ. Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine & Tobacco Research 2006;8(6):739-49.
    • (2006) Nicotine & Tobacco Research , vol.8 , Issue.6 , pp. 739-749
    • Hughes, J.R.1    Carpenter, M.J.2
  • 147
    • 31344443894 scopus 로고    scopus 로고
    • Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function
    • Johnson BA. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function. CNS Drugs 2005;19:873-896.
    • (2005) CNS Drugs , vol.19 , pp. 873-896
    • Johnson, B.A.1
  • 148
    • 66249112505 scopus 로고    scopus 로고
    • Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study
    • Kasliwal R, Wilton LV, Shakir SA. Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study. Drug Safety 2009;32(6):499-507.
    • (2009) Drug Safety , vol.32 , Issue.6 , pp. 499-507
    • Kasliwal, R.1    Wilton, L.V.2    Shakir, S.A.3
  • 149
    • 0032746548 scopus 로고    scopus 로고
    • Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland
    • Kelly C, McCreadie RG. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. American Journal of Psychiatry 1999;156(11):1751-7.
    • (1999) American Journal of Psychiatry , vol.156 , Issue.11 , pp. 1751-1757
    • Kelly, C.1    McCreadie, R.G.2
  • 152
    • 73949157937 scopus 로고    scopus 로고
    • The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
    • Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB. The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009. Schizophrenia Bulletin 2010;36(1):94-103.
    • (2010) Schizophrenia Bulletin , vol.36 , Issue.1 , pp. 94-103
    • Kreyenbuhl, J.1    Buchanan, R.W.2    Dickerson, F.B.3    Dixon, L.B.4
  • 153
    • 0036019541 scopus 로고    scopus 로고
    • Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: A critical evaluation of current evidence and directions for future research
    • Kumari V, Sharma T. Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: A critical evaluation of current evidence and directions for future research. Psychopharmacology 2002;162(2):97-101.
    • (2002) Psychopharmacology , vol.162 , Issue.2 , pp. 97-101
    • Kumari, V.1    Sharma, T.2
  • 155
    • 21844469006 scopus 로고    scopus 로고
    • Individual behavioural counselling for smoking cessation
    • Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001292.pub2]
    • (2005) Cochrane Database of Systematic Reviews , Issue.2
    • Lancaster, T.1    Stead, L.F.2
  • 157
    • 33644874561 scopus 로고    scopus 로고
    • Smoking bans in psychiatric inpatient settings? A review of the research
    • Lawn S, Pols R. Smoking bans in psychiatric inpatient settings? A review of the research. The Australian & New Zealand Journal of Psychiatry 2005;39(10):866-85.
    • (2005) The Australian & New Zealand Journal of Psychiatry , vol.39 , Issue.10 , pp. 866-885
    • Lawn, S.1    Pols, R.2
  • 159
    • 70350441886 scopus 로고    scopus 로고
    • Varenicline-induced mixed mood and psychotic episode in a patient with Schizoaffective Disorder
    • Liu ME, Tsai SJ, Yang ST. Varenicline-induced mixed mood and psychotic episode in a patient with Schizoaffective Disorder. CNS Spectrum 2009;14:346.
    • (2009) CNS Spectrum , vol.14 , pp. 346
    • Liu, M.E.1    Tsai, S.J.2    Yang, S.T.3
  • 162
    • 67651091553 scopus 로고    scopus 로고
    • Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia
    • Moss TG, Sacco KA, Allen TM, Weinberger AH, Vessicchio JC, George TP. Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia. Drug and Alcohol Dependence 2009;104(1-2):94-9.
    • (2009) Drug and Alcohol Dependence , vol.104 , Issue.1-2 , pp. 94-99
    • Moss, T.G.1    Sacco, K.A.2    Allen, T.M.3    Weinberger, A.H.4    Vessicchio, J.C.5    George, T.P.6
  • 163
    • 0030845507 scopus 로고    scopus 로고
    • Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers
    • Olincy A, Young DA, Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biological Psychiatry 1997;42(1):1-5.
    • (1997) Biological Psychiatry , vol.42 , Issue.1 , pp. 1-5
    • Olincy, A.1    Young, D.A.2    Freedman, R.3
  • 164
    • 10844237451 scopus 로고    scopus 로고
    • Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
    • Sacco KA, Bannon KL, George TP. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. Journal of Psychopharmacology 2004;18(4):457-74.
    • (2004) Journal of Psychopharmacology , vol.18 , Issue.4 , pp. 457-474
    • Sacco, K.A.1    Bannon, K.L.2    George, T.P.3
  • 165
    • 0034072939 scopus 로고    scopus 로고
    • Current models of nicotine dependence: What is known and what is needed to advance understanding of tobacco etiology among youth
    • Shadel WG, Shiffman S, Niaura R, Nichter M, Abrams DB. Current models of nicotine dependence: What is known and what is needed to advance understanding of tobacco etiology among youth. Drug and Alcohol Dependence 2000;59 Suppl 1:S9-22.
    • (2000) Drug and Alcohol Dependence , vol.59 , pp. S9-22
    • Shadel, W.G.1    Shiffman, S.2    Niaura, R.3    Nichter, M.4    Abrams, D.B.5
  • 166
    • 47149090424 scopus 로고    scopus 로고
    • Changes in psychiatric patients' thoughts about quitting smoking during a smoke-free hospitalization
    • Shmueli D, Fletcher L, Hall SE, Hall SM, Prochaska JJ. Changes in psychiatric patients' thoughts about quitting smoking during a smoke-free hospitalization. Nicotine & Tobacco Research 2008;10(5):875-81.
    • (2008) Nicotine & Tobacco Research , vol.10 , Issue.5 , pp. 875-881
    • Shmueli, D.1    Fletcher, L.2    Hall, S.E.3    Hall, S.M.4    Prochaska, J.J.5
  • 167
    • 18344399696 scopus 로고    scopus 로고
    • Group behaviour therapy programmes for smoking cessation
    • Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001007.pub2]
    • (2005) Cochrane Database of Systematic Reviews , Issue.2
    • Stead, L.F.1    Lancaster, T.2
  • 170
    • 84870417682 scopus 로고    scopus 로고
    • Combined pharmacotherapy and behavioural interventions for smoking cessation
    • Stead LF, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD008286.pub2]
    • (2012) Cochrane Database of Systematic Reviews , Issue.10
    • Stead, L.F.1    Lancaster, T.2
  • 172
    • 19644364115 scopus 로고    scopus 로고
    • Financial implications of cigarette smoking among individuals with schizophrenia
    • Steinberg ML, Williams JM, Ziedonis DM. Financial implications of cigarette smoking among individuals with schizophrenia. Tobacco Control 2004;13(2):206.
    • (2004) Tobacco Control , vol.13 , Issue.2 , pp. 206
    • Steinberg, M.L.1    Williams, J.M.2    Ziedonis, D.M.3
  • 173
    • 68949104832 scopus 로고    scopus 로고
    • Smoking Reduction and Cessation for People with Schizophrenia: Guidelines for General Practitioners
    • SANE Australia & Department of Psychiatry, University of Melbourne
    • Strasser K. Smoking Reduction and Cessation for People with Schizophrenia: Guidelines for General Practitioners. Smoking Reduction and Cessation for People with Schizophrenia:Guidelines for General Practitioners. SANE Australia & Department of Psychiatry, University of Melbourne, 2001.
    • (2001) Smoking Reduction and Cessation for People with Schizophrenia:Guidelines for General Practitioners
    • Strasser, K.1
  • 174
    • 0141684982 scopus 로고    scopus 로고
    • Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy
    • Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. Journal of American Medical Association 2003;290(12):1624-32.
    • (2003) Journal of American Medical Association , vol.290 , Issue.12 , pp. 1624-1632
    • Tunis, S.R.1    Stryer, D.B.2    Clancy, C.M.3
  • 176
    • 14944375305 scopus 로고    scopus 로고
    • Outcome criteria in smoking cessation trials: proposal for a common standard
    • West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100(3):299-303.
    • (2005) Addiction , vol.100 , Issue.3 , pp. 299-303
    • West, R.1    Hajek, P.2    Stead, L.3    Stapleton, J.4
  • 177
    • 26844517607 scopus 로고    scopus 로고
    • Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect
    • Williams JM, Ziedonis DM, Abanyie F, Steinberg ML, Foulds J, Benowitz NL. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophrenia Research 2005;79(2-3):323-35.
    • (2005) Schizophrenia Research , vol.79 , Issue.2-3 , pp. 323-335
    • Williams, J.M.1    Ziedonis, D.M.2    Abanyie, F.3    Steinberg, M.L.4    Foulds, J.5    Benowitz, N.L.6
  • 178
    • 33744969290 scopus 로고    scopus 로고
    • Snuffing out tobacco dependence. Ten reasons behavioral health providers need to be involved
    • Williams JM, Ziedonis DM. Snuffing out tobacco dependence. Ten reasons behavioral health providers need to be involved. Behavioral Healthcare 2006;26(5):27-31.
    • (2006) Behavioral Healthcare , vol.26 , Issue.5 , pp. 27-31
    • Williams, J.M.1    Ziedonis, D.M.2
  • 179
    • 33845963166 scopus 로고    scopus 로고
    • 2nd Edition. American Psychiatric Association
    • Workgroup on Substance Use Disorders, American Psychiatric Association Steering Committee on Practice Guidelines. Practice Guideline for the Treatment of Patients With Substance Use Disorders. 2nd Edition. American Psychiatric Association, 2006.
    • (2006) Practice Guideline for the Treatment of Patients With Substance Use Disorders
  • 181
    • 58149483940 scopus 로고    scopus 로고
    • Smoking restrictions and treatment for smoking: policies and procedures in psychiatric inpatient units in Australia
    • Wye PM, Bowman JA, Wiggers JH, Baker A, Knight J, Carr VJ, et al. Smoking restrictions and treatment for smoking: policies and procedures in psychiatric inpatient units in Australia. Psychiatric Service 2009;60(1):100-7.
    • (2009) Psychiatric Service , vol.60 , Issue.1 , pp. 100-107
    • Wye, P.M.1    Bowman, J.A.2    Wiggers, J.H.3    Baker, A.4    Knight, J.5    Carr, V.J.6
  • 183
    • 36448964521 scopus 로고    scopus 로고
    • Program and System Level Interventions to Address Tobacco Amongst Individuals with Schizophrenia
    • Ziedonis D, Parks J, Zimmermann MH, McCabe P. Program and System Level Interventions to Address Tobacco Amongst Individuals with Schizophrenia. Journal of Dual Diagnosis 2007;3(3/4):151-175.
    • (2007) Journal of Dual Diagnosis , vol.3 , Issue.3-4 , pp. 151-175
    • Ziedonis, D.1    Parks, J.2    Zimmermann, M.H.3    McCabe, P.4
  • 185
    • 77951734628 scopus 로고    scopus 로고
    • Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis
    • Tsoi DT, Porwal M, Webster AC. Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis. British Journal of Psychiatry 2010;196:346-353.
    • (2010) British Journal of Psychiatry , vol.196 , pp. 346-353
    • Tsoi, D.T.1    Porwal, M.2    Webster, A.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.